Comments closedOur research group is truly grateful for the overwhelming support we’ve received from the community over the past few months through emails, letters, and phone calls advocating for the continuation of our wastewater monitoring system.
We’ve gained invaluable insights into how this information is essential for community members facing health challenges, and we are thrilled to continue providing this vital service. A heartfelt thank you to OPH, CHEO, and CHEO-RI for their unwavering support.
Tag: research
Want To Prevent Long Covid? Should You Take Metformin Or Paxlovid?
Previously, I wrote about Paxlovid being underprescribed for treating acute Covid in patients at high risk for serious illness. The FDA granted an Emergency Use Authorization based on data showing that “Paxlovid significantly reduced the proportion of people with Covid-19 related hospitalization or death” by 88% compared to placebo.
In unvaccinated people, Paxlovid was also associated with a 26% lower risk of long Covid in a study by Ziyad Al-Aly.
The data on Paxlovid for those previously vaccinated is mixed. A smaller study from the University of California at San Francisco found no benefit in people who had been previously vaccinated.
Comments closedWhat Repeat COVID Infections Do to Your Body, According to Science
These days, it’s tempting to compare COVID-19 with the common cold or flu. It can similarly leave you with a nasty cough, fever, sore throat—the full works of respiratory symptoms. And it’s also become a part of the societal fabric, perhaps something you’ve resigned yourself to catching at least a few times in your life (even if you haven’t already). But let’s not forget: SARS-CoV-2 (the virus responsible for COVID) is still relatively new, and researchers are actively investigating the toll of reinfection on the body. While there are still a lot of unknowns, one thing seems to be increasingly true: Getting COVID again and again is a good deal riskier than repeat hits of its seasonal counterparts.
It turns out, SARS-CoV-2 is more nefarious than these other contagious bugs, and our immune response to it, often larger and longer-lasting. COVID has a better ability to camouflage itself in the body, “and it has the keys to the kingdom in the sense that it can unlock any cell and get in,” says Esther Melamed, PhD, an assistant professor in the department of neurology at Dell Medical School, University of Texas Austin, and the research director of the Post-COVID-19 program at UT Health Austin. That’s because SARS-CoV-2 binds to ACE2 receptors, which exist in cells all over your body, from your heart to your gut to your brain. (By contrast, cold and flu viruses replicate mostly in your respiratory tract.)
Comments closedStudy: Individuals with pre-existing disabilities had long COVID at much higher rates than peers
The COVID-19 pandemic has been especially hard on individuals with disabilities. New research from the University of Kansas shows that this population is also experiencing long COVID at significantly higher rates than the general population, which exacerbates existing barriers to accessing care.
Researchers from KU’s Institute for Health and Disability Policy Studies at the KU Life Span Institute and the Patient-Led Research Collaborative published a study showing that more than 40% of individuals with pre-existing disabilities who had tested positive for COVID-19 experienced long COVID, defined as symptoms lasting three months or longer. This rate is more than twice the 18.9% of individuals without disabilities who contracted COVID and experienced long COVID symptoms.
Research has long documented that individuals with disabilities face barriers to health care access and experience poorer health outcomes than their nondisabled peers. However, many studies during the pandemic have only asked about disabilities present at the time of the survey rather than whether individuals had a disability prior to the start of the pandemic. The research team compared data from the 2022 National Survey on Health and Disability, conducted by the IHDPS, to the Household Pulse Survey conducted by the Centers for Disease Control and Prevention.
Comments closedOntario dropped wastewater testing early, with no plan for feds to step in: documents
The Ontario government abruptly ended its wastewater surveillance program earlier than planned this summer, despite having funding in place until the end of September and being warned that the move could leave gaps in crucial information for public health, internal documents indicate.
The government pulled the plug at the end of July on the globally praised program that, at its peak, covered about 75 per cent of the province.
The program, overseen by the Ministry of the Environment, provided an early warning signal to health officials about the spread of COVID-19, influenza, RSV and other infectious diseases, based on wastewater testing.
Documents obtained through access to information by the Ottawa Citizen indicate that the province’s hasty decision last spring to end the program came before Ontario’s Ministry of Health had even begun negotiations with the federal government about taking over wastewater surveillance.
Comments closedCovid associated with increased risk for hearing loss in young adults
Covid can lead to the loss of smell and taste, but another sense may also be at risk.
A recent study published in the Lancet’s eClinicalMedicine journal reported that a positive coronavirus diagnosis was associated with a more than threefold increase in risk for subsequent hearing loss in young adults.
The effects of covid can linger and affect nearly every organ system, increasing the risk for cardiovascular diseases, diabetes and cognitive impairment.
The new research may be an “alert” that “covid-19 may be an independent risk factor for hearing loss and sudden sensorineural hearing loss among young adults,” said Hye Jun Kim, a biomedical sciences PhD candidate at Seoul National University and an author of the study.
Comments closedThere’s a gaping hole in Canada’s COVID tracking
The Government of Canada’s website tracks the number of hospitalizations and deaths from acute COVID-19. What it fails to include are the hospitalizations and deaths that result from COVID’s longer-term health consequences.
Even mild cases carry risk, but COVID most frequently wallops people after severe cases, especially when hospitalized. Of the nearly 300,000 Canadians hospitalized so far, over half likely have — or will — suffer life-changing health consequences, sometimes years after having recovered from the acute illness. These risks climb with repeated infections.
Hospitalizations and deaths from COVID-19 are often delayed. Like high blood pressure, SARS CoV-2 can gradually damage the inner lining of blood vessels. This by itself, is painless. While it happens to people following mild cases of COVID, it’s far more likely after severe ones, especially after hospitalization. This doubles the downstream risk of having a heart attack, stroke or blood clot in the lung. It triples the risk of developing an abnormal heart rhythm, including atrial fibrillation.
Comments closedNIH-funded study finds long COVID affects adolescents differently than younger children
Scientists investigating long COVID in youth found similar but distinguishable patterns between school-age children (ages 6-11 years) and adolescents (ages 12-17 years) and identified their most common symptoms. The study, supported by the National Institutes of Health (NIH) and published in JAMA, comes from research conducted through the NIH’s Researching COVID to Enhance Recovery (RECOVER) Initiative, a wide-reaching effort to understand, diagnose, treat, and prevent long COVID, a condition marked by symptoms and health problems that linger after an infection with SARS-CoV-2, the virus that causes COVID-19.
Children and adolescents were found to experience prolonged symptoms after SARS-CoV-2 infection in almost every organ system with most having symptoms affecting more than one system.
Comments closedCOVID-related loss of smell tied to changes in the brain
A new study of 73 adults recovering from COVID-19 finds that those who lost their sense of smell showed behavioral, functional, and structural brain changes.
Researchers in Chile conducted cognitive screening, performance on a decision-making task, functional testing, and magnetic resonance imaging (MRI) results with 73 patients after mild to moderate COVID-19 infection and 27 COVID-naïve patients with infections from other pathogens. Two follow-up sessions were conducted 15 days apart.
Comments closedLong COVID has cost the Australian economy billions in lost work hours, new research says
In short:
A new study has found about $9.6 billion was lost in economic productivity due to long COVID in 2022.
Researchers say that represented about a quarter of Australia’s real gross domestic product growth for that year.
What’s next?
Some experts are calling on state and federal governments, as well as policymakers, to put greater focus on long COVID.
Comments closedLong COVID leads to missed work days, economic loss
About 14% of participants in a new long-COVID study from Yale said they didn’t return to work in the months after their infection, suggesting that the condition results in major economic losses. The study is published in PLOS One.
The study was based on the outcomes of 6,000 participants at eight study sites in Illinois, Connecticut, Washington, Pennsylvania, Texas, and California from 2020 through 2022 as part of the Innovative Support for Patients with SARS-CoV-2 Infections Registry, or INSPIRE study.
Comments closedNew studies estimate long-COVID rates, identify risk factors
Comments closedAs new variants continue to emerge and infect people, older adults remain highly vulnerable to long-term health effects from this pathogen. Continued multidisciplinary research is needed to understand and prevent long COVID to reduce morbidity and mortality and maintain quality of life in older adults.
About 400 Million People Worldwide Have Had Long Covid, Researchers Say
About 400 million people worldwide have been afflicted with long Covid, according to a new report by scientists and other researchers who have studied the condition. The team estimated that the economic cost — from factors like health care services and patients unable to return to work — is about $1 trillion worldwide each year, or about 1 percent of the global economy.
The report, published Friday in the journal Nature Medicine, is an effort to summarize the knowledge about and effects of long Covid across the globe four years after it first emerged.
It also aims to “provide a road map for policy and research priorities,” said one author, Dr. Ziyad Al-Aly, the chief of research and development at the V.A. St. Louis Health Care System and a clinical epidemiologist at Washington University in St. Louis. He wrote the paper with several other leading long Covid researchers and three leaders of the Patient-Led Research Collaborative, an organization formed by long Covid patients who are also professional researchers.
Comments closedLong COVID is a $1 trillion problem with no cure. Experts plead for governments to wake up
For months, governmental officials around the world have appeared to want to forgo discussing the specter of long COVID. As a new review makes clear, that is wishful thinking—and the latest COVID variants may well kick long COVID into overdrive, a scenario that researchers and experts have been warning about for some time.
“I think they (government agencies) are itching to pretend that COVID is over and that long COVID does not exist,” says Ziyad Al-Aly, director of the Clinical Epidemiology Center at Veterans Affairs St. Louis Health Care System and lead author of the review. “It is much more pleasant to pretend as if emergency department visits and hospitalizations haven’t been rising sharply this summer.”
In a Nature Medicine review this week, Al-Aly and several other top researchers lay out a difficult truth: Long COVID has already affected an estimated 400 million people worldwide, a number the authors say is likely conservative, at an economic cost of about $1 trillion annually—equivalent to 1% of the global economy.
Comments closedSanders Proposes ‘Moonshot’ Bill to Combat Long Covid Crisis
Comments closedFor far too long, millions of Americans suffering from long Covid have had their symptoms dismissed or ignored — by the medical community, by the media, and by Congress. That is unacceptable and has got to change.
The legislation that we have introduced finally recognizes that long Covid is a public health emergency and provides an historic investment into research, development, and education needed to counter the effects of this terrible disease. Congress must act now to ensure treatments are developed and made available for Americans struggling with long Covid. Yes. It is time for a long Covid moonshot.
The Risks of Killing a COVID Early Warning System
COVID-19 is surging in parts of North America and Europe, and even played a role in ending the presidential campaign of 81-year-old Joe Biden, who was infected for the third time last month.
Nevertheless, on Wednesday the Ontario government shut down its early warning system to detect COVID and other emerging diseases.
Doctors, citizens and researchers are calling the decision to kill the province’s wastewater disease surveillance program both wrong-headed and dangerous. Ending the program will make it harder to track and thwart viral outbreaks, they say, and thereby increase the burden on Ontario’s understaffed hospitals, which experienced more than 1,000 emergency room closures last year.
“Pandemics do not end because science has been muzzled,” Dr. Iris Gorfinkel, a well-known Toronto physician and clinical researcher, told the CBC.
In emails to politicians, more than 5,000 citizens have demanded restoration of the program, with little effect.
Comments closed